Clinical Trial Update: The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial investigates the optimal timing of primaquine after artemisinin-based combination therapy to prevent malaria transmission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artemisinin-based combination therapy (ACT)
• Primaquine (primaquine)

Snippet

Sponsor: Kilimanjaro Clinical Research Institute | Conditions: Malaria Transmission | Phase 4 | Status: UNKNOWN